eculizumab
|
||||||||||||||
|
|
|
||||||||||||
|
||||||||||||||
Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.
eculizumab |
||||||||||||||||||||||||||||||||||||||||
| navigate by keyword : ahus antibody atypical biological biosimilar biotech biotechnology cascade complement component disease drug eculizumab excessive expensive hemoglobinuria hemolytic immunoglobulin immunology infusion inhibitor injection inn mab monoclonal nocturnal nomenclature orphan paroxysmal peptide pnh price protein syndrome terminal uremic |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Eculizumab monoclonal antibody drug. Targets complement component 5 and indications for use include paroxysmal nocturnal hemoglobinuria (PNH) and Atypical hemolytic uremic syndrome (aHUS). Generic name and stylized antibody representation |
||||||||||||||||||||||||||||||||||||||||
|
Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners. |
||||||||||||||||||||||||||||||||||||||||